Genotypic glucose-6-phosphate dehydrogenase (G6PD) deficiency protects against Plasmodium falciparum infection in individuals living in Ghana.
<h4>Introduction</h4>The global effort to eradicate malaria requires a drastic measure to terminate relapse from hypnozoites as well as transmission via gametocytes in malaria-endemic areas. Primaquine has been recommended for the treatment of P. falciparum gametocytes and P. vivax hypno...
Enregistré dans:
Auteurs principaux: | Linda Eva Amoah, Kwame Kumi Asare, Donu Dickson, Joana Abankwa, Abena Busayo, Dorcas Bredu, Sherifa Annan, George Adu Asumah, Nana Yaw Peprah, Alexander Asamoah, Keziah Laurencia Malm |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2a2704f4ee454cfdac272ff3f5d577b8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
par: Y ZahedPasha, et autres
Publié: (2006) -
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
par: Saeed Daneshmandi, et autres
Publié: (2021) -
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
par: Joanna L Gillis, et autres
Publié: (2021) -
Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator
par: Sunhee Hwang, et autres
Publié: (2018) -
Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance
par: Ruilong Liu, et autres
Publié: (2019)